Article 23 Dec 2025 Charting A Path Forward In 2026: Holland & Knight's Year-End Healthcare Antitrust Report United States Healthcare
Article 17 Sep 2025 California's Private Equity Bills Head To Gov. Newsom For Round 2: Are They Still Redundant? United States Healthcare
Article 27 May 2025 Podcast - Navigating The New Landscape Of Private Equity In Healthcare United States Healthcare
Article 15 May 2025 New York Budget Omits Changes To State's "Disclosure Of Material Transactions" Law United States Healthcare
Article 07 Apr 2025 Q2 2025 Update On State Efforts To Regulate Healthcare Consolidation United States Healthcare
Article 19 Feb 2025 New Year, Same Bill: California Reintroduces Bill Aimed At Healthcare Private Equity Investment United States Healthcare
Article 30 Jan 2025 A Year-End Report For Healthcare Antitrust And What To Expect Later In 2025 United States Anti-trust
Article 14 Nov 2024 Illinois Dental Practices Face New Third-Party Financing Guardrails In 2025 United States Healthcare
Article 13 Nov 2024 5 Key Takeaways From Panel Discussion With The California Office Of Health Care Affordability United States Healthcare
Article 21 Oct 2024 Podcast - What's Next After Gov. Gavin Newsom's Veto In California? United States Healthcare
Article 16 Oct 2024 5 Key Antitrust Takeaways From Holland & Knight's Panel At Nashville Healthcare Sessions 2024 United States Anti-trust
Article 03 Oct 2024 California Governor Vetoes Assembly Bill 3129: What's Next? United States Healthcare
Article 16 Sep 2024 California Ends The Legislative Session With Expanded Reporting Requirements, Less Clarity United States Healthcare
Article 13 Aug 2024 Friendly PC Model Survives In California After Envision Healthcare Litigation Settlement United States Healthcare
Article 02 Aug 2024 Healthcare Private Equity Transactions Under Scrutiny: Midyear Review United States Healthcare
Article 26 Jun 2024 California Court Decision Further Scrutinizes The Friendly PC Model – Now What? United States Healthcare
Article 07 Jun 2024 Recent Ruling Shows Healthcare Private Equity Firms A Path Through The New Antitrust Era United States Anti-trust